These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5981285)

  • 1. [Endometrial morphology after sequential and combined treatment with different progestins].
    Andreoli C; Vischi F
    Minerva Ginecol; 1966 Jul; 18(14):783-9. PubMed ID: 5981285
    [No Abstract]   [Full Text] [Related]  

  • 2. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model.
    Mönckedieck V; Sannecke C; Husen B; Kumbartski M; Kimmig R; Tötsch M; Winterhager E; Grümmer R
    Mol Hum Reprod; 2009 Oct; 15(10):633-43. PubMed ID: 19671596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of progestins on human endometrium in vitro].
    Charpin C; Illouz S; Dales JP; Lavaut MN; Allasia C; Boubli L
    Bull Acad Natl Med; 2002; 186(1):125-45; discussion 145-6. PubMed ID: 12146137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding.
    Rogers PA; Martinez F; Girling JE; Lederman F; Cann L; Farrell E; Tresserra F; Patel N
    Hum Reprod; 2005 Dec; 20(12):3341-7. PubMed ID: 16085661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The human endometrium under the influence of the norsteroids].
    Vokaer R; Bayot D
    Gynecol Prat; 1964; 15(4):283-7. PubMed ID: 5896482
    [No Abstract]   [Full Text] [Related]  

  • 7. [Histochemical changes in the endometrium of sterile women following the administration of ovarian hormones].
    Tichý M; Dyková H; Havránek F
    Cesk Gynekol; 1967 Feb; 32(1):24-6. PubMed ID: 6044947
    [No Abstract]   [Full Text] [Related]  

  • 8. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various types and dosages of progestogens on the postmenopausal endometrium.
    Whitehead MI; Townsend PT; Pryse-Davies J; Ryder T; Lane G; Siddle NC; King RJ
    J Reprod Med; 1982 Aug; 27(8 Suppl):539-48. PubMed ID: 7131447
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of estrogen and progestogen on nitric oxide content in rat endometrium.
    Zha YP
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):283. PubMed ID: 12651256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo progestin treatments inhibit nitric oxide and endothelin-1-induced bovine endometrial prostaglandin (PG) E (PGE) secretion in vitro.
    Weems YS; Randel RD; Tatman S; Lewis AW; Neuendorff DA; Weems CW
    Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):264-78. PubMed ID: 16303621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of emergency contraception with gestrinone: a preliminary investigation.
    Gao X; Wu E; Chen G
    Contraception; 2007 Sep; 76(3):221-7. PubMed ID: 17707720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial bleeding during hormone therapy: the effect of progestogens.
    Archer DF
    Maturitas; 2007 May; 57(1):71-6. PubMed ID: 17412535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestagenic effects of tibolone are target gene-specific in human endometrial cells.
    Zhang W; Mazella J; Kloosterboer HJ; Tseng L
    J Soc Gynecol Investig; 2006 Sep; 13(6):459-65. PubMed ID: 16879988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin treatment induces apoptosis and modulates transforming growth factor-beta in the uterine endometrium.
    Rodriguez GC; Rimel BJ; Watkin W; Turbov JM; Barry C; Du H; Maxwell GL; Cline JM
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):578-84. PubMed ID: 18349275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial structural and inflammatory changes with exogenous progestogens.
    Hickey M; Salamonsen LA
    Trends Endocrinol Metab; 2008 Jul; 19(5):167-74. PubMed ID: 18434186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
    Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
    Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.